{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:15:52Z","timestamp":1783354552607,"version":"3.54.6"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001006","name":"The Breast Cancer Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jgo.2026.103032","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:25:40Z","timestamp":1781688340000},"page":"103032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of life and function in younger and older women treated for non-metastatic breast cancer: Three or more years post primary treatment"],"prefix":"10.1016","volume":"17","author":[{"given":"Karie","family":"Turley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis C.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyman B.","family":"Muss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.","family":"Nyrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jgo.2026.103032_bb0005","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","article-title":"Past, present, and future challenges in breast cancer treatment","volume":"32","author":"Sledge","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2026.103032_bb0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.21037\/gs.2018.11.10","article-title":"Evolution of radiotherapy techniques in breast conservation treatment","volume":"7","author":"Boyages","year":"2018","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"16","key":"10.1016\/j.jgo.2026.103032_bb0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/jnci\/djj305","article-title":"Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer","volume":"98","author":"Hassett","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jgo.2026.103032_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4048\/jbc.2013.16.2.229","article-title":"Does chemotherapy really affect the quality of life of women with breast cancer?","volume":"16","author":"Hwang","year":"2013","journal-title":"J Breast Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2026.103032_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124169","article-title":"The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patients","volume":"10","author":"Tachi","year":"2015","journal-title":"PloS One"},{"issue":"26","key":"10.1016\/j.jgo.2026.103032_bb0035","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","article-title":"Side effects of adjuvant treatment of breast cancer","volume":"344","author":"Shapiro","year":"2001","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jgo.2026.103032_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225643","article-title":"Endocrine treatment for breast cancer patients revisited-history, standard of care, and possibilities of improvement","volume":"13","author":"Nabieva","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21037\/gs.2017.09.07","article-title":"The evolution of mastectomy surgical technique: from mutilation to medicine","volume":"7","author":"Freeman","year":"2018","journal-title":"Gland Surg"},{"key":"10.1016\/j.jgo.2026.103032_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.622621","article-title":"Evolving trends in surgical Management of Breast Cancer: an analysis of 30 years of practice changing papers","volume":"11","author":"Keelan","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2026.103032_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2020.07.037","article-title":"Prevalence of fatigue in patients with Cancer: a systematic review and meta-analysis","volume":"61","author":"Al Maqbali","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.jgo.2026.103032_bb0060","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.1038\/s41598-023-39046-0","article-title":"Prevalence of cancer-related fatigue based on severity: a systematic review and meta-analysis","volume":"13","author":"Kang","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.31557\/APJCP.2023.24.3.769","article-title":"Prevalence and impact of fatigue on quality of life (QOL) of cancer patients undergoing chemotherapy: a systematic review and meta-analysis","volume":"24","author":"Muthanna","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.jgo.2026.103032_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.maturitas.2015.04.010","article-title":"The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review","volume":"82","author":"Maass","year":"2015","journal-title":"Maturitas"},{"issue":"48","key":"10.1016\/j.jgo.2026.103032_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023399","article-title":"Depression and survival of breast cancer patients: a protocol for systematic review and meta-analysis","volume":"99","author":"Zhu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.jgo.2026.103032_bb0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","article-title":"Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects","volume":"21","author":"Di Nardo","year":"2022","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pmn.2023.12.013","article-title":"Neuropathic pain affects quality of life in breast Cancer survivors with chemotherapy-induced peripheral neuropathy","volume":"25","author":"Jheng","year":"2024","journal-title":"Pain Manag Nurs"},{"issue":"2","key":"10.1016\/j.jgo.2026.103032_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298928","article-title":"Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer","volume":"19","author":"Wiranata","year":"2024","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jgo.2026.103032_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000497233","article-title":"Long-term side effects of adjuvant therapy in primary breast cancer patients: results of a web-based survey","volume":"14","author":"Haidinger","year":"2019","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.jgo.2026.103032_bb0100","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41598-024-53151-8","article-title":"Comparative overall survival of CDK4\/6 inhibitors in combination with endocrine therapy in advanced breast cancer","volume":"14","author":"Kappel","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jgo.2026.103032_bb0105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1200\/JCO-24-02086","article-title":"Abemaciclib plus fulvestrant in advanced breast cancer after progression on CDK4\/6 inhibition: results from the phase III postMONARCH trial","volume":"43","author":"Kalinsky","year":"2025","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2026.103032_bb0110","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1245\/s10434-024-15682-2","article-title":"Persistent pain after breast cancer treatment, an underreported burden for breast cancer survivors","volume":"31","author":"Strijbos","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-010-1532-5","article-title":"Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model","volume":"68","author":"Francescutti","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jgo.2026.103032_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2022.04.005","article-title":"Physical functioning, frailty and risks of locally-advanced breast cancer among older women","volume":"64","author":"Coleman","year":"2022","journal-title":"Breast"},{"issue":"15","key":"10.1016\/j.jgo.2026.103032_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152718","article-title":"Association between cognitive function and physical function, frailty, and quality of life in older breast Cancer survivors","volume":"16","author":"Von Ah","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jgo.2026.103032_bb0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s12282-019-00974-3","article-title":"Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer","volume":"26","author":"Usiskin","year":"2019","journal-title":"Breast Cancer"},{"issue":"18","key":"10.1016\/j.jgo.2026.103032_bb0135","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.1002\/cam4.6456","article-title":"The impact of preexisting comorbidities on receipt of cancer therapy among women with stage I-III breast cancer in the Detroit research on Cancer survivors cohort","volume":"12","author":"Raychaudhuri","year":"2023","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4048\/jbc.2023.26.e23","article-title":"Predictors of decreased quality of life in breast Cancer survivors five years after diagnosis","volume":"26","author":"Herbert","year":"2023","journal-title":"J Breast Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2026.103032_bb0145","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s11764-015-0438-y","article-title":"Depression and quality of life before and after breast cancer diagnosis in older women from the Women\u2019s Health Initiative","volume":"9","author":"Jones","year":"2015","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jgo.2026.103032_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2407-8-330","article-title":"Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study","volume":"8","author":"Montazeri","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jad.2011.09.012","article-title":"Combined anxiety and depressive symptoms before diagnosis of breast cancer","volume":"136","author":"Van Esch","year":"2012","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.jgo.2026.103032_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.jgo.2026.103032_bb0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jgo.2026.103032_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.920739","article-title":"Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: a single-center registry experience","volume":"12","author":"Laughlin","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jgo.2026.103032_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103781","article-title":"Psychometric properties of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE\u00ae) in breast cancer patients: the prospective observational multicenter VIP study","volume":"77","author":"Caminiti","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2026.103032_bb0180","first-page":"1","article-title":"An overview of chemotoxicity and radiation toxicity in cancer therapy","volume":"155","author":"Yazbeck","year":"2022","journal-title":"Adv Cancer Res"},{"issue":"7","key":"10.1016\/j.jgo.2026.103032_bb0185","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jgo.2026.103032_bb0190","series-title":"BRFSS Questionnaire","author":"Centers for Disease Control and Prevention","year":"2011"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0195","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of Cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2026.103032_bb0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cncr.10245","article-title":"Fatigue in cancer patients compared with fatigue in the general United States population","volume":"94","author":"Cella","year":"2002","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jgo.2026.103032_bb0205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. Evaluation Studies Research Support, N.I.H., Extramural","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.jgo.2026.103032_bb0210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ijgc-00009577-200311000-00003","article-title":"Psychometric evaluation of the functional assessment of Cancer therapy\/gynecologic oncology group-neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.jgo.2026.103032_bb0215","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1017\/S1355617714000241","article-title":"Reliability and validity of composite scores from the NIH toolbox cognition battery in adults","volume":"20","author":"Heaton","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"10.1016\/j.jgo.2026.103032_bb0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","article-title":"Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B","volume":"55","author":"Fallowfield","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"10.1016\/j.jgo.2026.103032_bb0225","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.ejca.2015.06.113","article-title":"Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors","volume":"51","author":"Brier","year":"2015","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.jgo.2026.103032_bb0230","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/cncr.29407","article-title":"Development and validation of the Penn arthralgia aging scale among breast cancer survivors","volume":"121","author":"Brier","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2026.103032_bb0235","series-title":"Patient-Reported Symptom Severity, Interference With Daily Activities, and Adverse Events in Older and Younger Women Receiving Chemotherapy for Early Breast Cancer","author":"Nyrop","year":"2020"},{"issue":"2","key":"10.1016\/j.jgo.2026.103032_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jgo.2012.01.005","article-title":"Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803)","volume":"3","author":"Cohen","year":"2012","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2026.103032_bb0245","doi-asserted-by":"crossref","first-page":"e250614","DOI":"10.1001\/jamanetworkopen.2025.0614","article-title":"Frailty trajectories following adjuvant chemotherapy and mortality in older women with breast cancer","volume":"8","author":"Duchesneau","year":"2025","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406826001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406826001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:30:24Z","timestamp":1783351824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406826001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1879406826001864"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2026.103032","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and function in younger and older women treated for non-metastatic breast cancer: Three or more years post primary treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2026.103032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103032"}}